One possibility is that while the integrity of the choroidal vasculature is altered in diabetic retinopathy, the mechanism by which anti-VEGF therapy decreases retinal edema and improves visual acuity does not involve reversing the alterations to choroidal vasculature. This evidence concerns the gene VEGFA and diabetic retinopathy.